Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism

Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism

Abstract Background Current guidelines recommend discontinuing mineralocorticoid receptor antagonists (MRA) at least 4 weeks before adrenal venous sampling (AVS) in primary aldosteronism (PA) to avoid interference with the lateralization index (LI). However, discontinuing MRA can cause hypertension...

Full description

Saved in:
Bibliographic Details
Main Authors: Sittikul Thipbumrung, Worapaka Manosroi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Endocrine Disorders
Subjects:
Adrenal venous sampling
Primary aldosteronism
Mineralocorticoid receptor antagonist
Lateralization index
Plasma Renin activity
Clinical outcome
Online Access:https://doi.org/10.1186/s12902-025-01987-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12902-025-01987-0

Similar Items